Free Trial

ALX Oncology (ALXO) Earnings Date, Estimates & Call Transcripts

ALX Oncology logo
$0.46 -0.02 (-3.17%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.48 +0.02 (+3.95%)
As of 05/23/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALX Oncology Earnings Summary

ALX Oncology issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.58, which missed analysts' consensus estimates of -$0.47 by $0.11. With a trailing EPS of -$2.47, ALX Oncology's earnings are expected to grow next year, from ($2.76) to ($2.50) per share.

Latest Q1
Earnings Date
May. 8Estimated
Consensus EPS
(May. 8)
-$0.47
Actual EPS
(May. 8)
-$0.58 Missed By -$0.11

Q1 2025 Earnings Resources

Get ALX Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ALX Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALXO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALX Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.61-$0.61-$0.61
Q2 20251-$0.66-$0.66-$0.66
Q3 20251-$0.68-$0.68-$0.68
Q4 20251-$0.61-$0.61-$0.61

ALX Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025-$0.47-$0.58 -$0.11-$0.58--
8/8/2024--$0.77-$0.76+$0.01-$0.76--
5/9/2024Q1 2024-$0.87-$0.71+$0.16-$0.71--
3/7/2024Q4 2023-$0.84-$0.93 -$0.09-$0.93--
11/13/2023Q3 2023-$0.86-$1.24 -$0.38-$1.24--
8/10/2023Q2 2023-$0.85-$0.84+$0.01-$0.84--

ALX Oncology Earnings - Frequently Asked Questions

ALX Oncology (NASDAQ:ALXO) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on ALXO's earnings history.

In the previous quarter, ALX Oncology (NASDAQ:ALXO) missed the analysts' consensus estimate of ($0.47) by $0.11 with a reported earnings per share (EPS) of ($0.58). Learn more on analysts' earnings estimate vs. ALXO's actual earnings.

ALX Oncology (NASDAQ:ALXO) has a recorded net income of -$160.80 million. ALXO has generated -$2.47 earnings per share over the last four quarters.

ALX Oncology's earnings are expected to grow from ($2.76) per share to ($2.50) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ALXO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners